PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
GMED vs. SPY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between GMED and SPY is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.5

Performance

GMED vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Globus Medical, Inc. (GMED) and SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

400.00%450.00%500.00%550.00%600.00%NovemberDecember2025FebruaryMarchApril
459.26%
409.31%
GMED
SPY

Key characteristics

Sharpe Ratio

GMED:

1.29

SPY:

0.68

Sortino Ratio

GMED:

2.33

SPY:

0.98

Omega Ratio

GMED:

1.30

SPY:

1.13

Calmar Ratio

GMED:

1.03

SPY:

0.95

Martin Ratio

GMED:

5.67

SPY:

3.13

Ulcer Index

GMED:

7.43%

SPY:

3.03%

Daily Std Dev

GMED:

32.75%

SPY:

13.89%

Max Drawdown

GMED:

-47.91%

SPY:

-55.19%

Current Drawdown

GMED:

-19.10%

SPY:

-7.62%

Returns By Period

In the year-to-date period, GMED achieves a -8.72% return, which is significantly lower than SPY's -3.39% return. Over the past 10 years, GMED has underperformed SPY with an annualized return of 11.54%, while SPY has yielded a comparatively higher 12.54% annualized return.


GMED

YTD

-8.72%

1M

-4.73%

6M

7.89%

1Y

45.70%

5Y*

13.71%

10Y*

11.54%

SPY

YTD

-3.39%

1M

-3.01%

6M

-0.13%

1Y

10.19%

5Y*

19.68%

10Y*

12.54%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

GMED vs. SPY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GMED
The Risk-Adjusted Performance Rank of GMED is 8787
Overall Rank
The Sharpe Ratio Rank of GMED is 8888
Sharpe Ratio Rank
The Sortino Ratio Rank of GMED is 8989
Sortino Ratio Rank
The Omega Ratio Rank of GMED is 8787
Omega Ratio Rank
The Calmar Ratio Rank of GMED is 8484
Calmar Ratio Rank
The Martin Ratio Rank of GMED is 8888
Martin Ratio Rank

SPY
The Risk-Adjusted Performance Rank of SPY is 6565
Overall Rank
The Sharpe Ratio Rank of SPY is 6262
Sharpe Ratio Rank
The Sortino Ratio Rank of SPY is 6161
Sortino Ratio Rank
The Omega Ratio Rank of SPY is 6161
Omega Ratio Rank
The Calmar Ratio Rank of SPY is 7272
Calmar Ratio Rank
The Martin Ratio Rank of SPY is 6767
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

GMED vs. SPY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Globus Medical, Inc. (GMED) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for GMED, currently valued at 1.29, compared to the broader market-2.00-1.000.001.002.003.00
GMED: 1.29
SPY: 0.68
The chart of Sortino ratio for GMED, currently valued at 2.33, compared to the broader market-6.00-4.00-2.000.002.004.00
GMED: 2.33
SPY: 0.98
The chart of Omega ratio for GMED, currently valued at 1.30, compared to the broader market0.501.001.502.00
GMED: 1.30
SPY: 1.13
The chart of Calmar ratio for GMED, currently valued at 1.03, compared to the broader market0.001.002.003.004.005.00
GMED: 1.03
SPY: 0.95
The chart of Martin ratio for GMED, currently valued at 5.67, compared to the broader market-5.000.005.0010.0015.0020.00
GMED: 5.67
SPY: 3.13

The current GMED Sharpe Ratio is 1.29, which is higher than the SPY Sharpe Ratio of 0.68. The chart below compares the historical Sharpe Ratios of GMED and SPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00NovemberDecember2025FebruaryMarchApril
1.29
0.68
GMED
SPY

Dividends

GMED vs. SPY - Dividend Comparison

GMED has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.27%.


TTM20242023202220212020201920182017201620152014
GMED
Globus Medical, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
SPDR S&P 500 ETF
1.27%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%1.87%

Drawdowns

GMED vs. SPY - Drawdown Comparison

The maximum GMED drawdown since its inception was -47.91%, smaller than the maximum SPY drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for GMED and SPY. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-19.10%
-7.62%
GMED
SPY

Volatility

GMED vs. SPY - Volatility Comparison

Globus Medical, Inc. (GMED) has a higher volatility of 9.55% compared to SPDR S&P 500 ETF (SPY) at 5.76%. This indicates that GMED's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%NovemberDecember2025FebruaryMarchApril
9.55%
5.76%
GMED
SPY
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab